Prokar Dasgupta

Loading
Prokar Dasgupta

Prokar Dasgupta

Professor of Surgery, King's College London, King’s Health Partners
Prokar Dasgupta, King’s Health Partners Foundation Professor of Surgery, is internationally reputed as a clinician-scientist, educator, polymath and 10th Editor-in-Chief of the British Journal of Urology International (BJUI). He pioneered robotic surgery in Urology in the UK, and with the help of The Urology Foundation, trained and mentored several consultant surgeons and over 30 fellows both nationally and internationally. He was the first to develop image guided and 3D printed prostatectomies, indentation probes for precise localisation of tumours and is Ambassador for the KCL-Ericsson 5G Global health program in telemedicine. He was Chief Investigator for the world’s first randomised controlled trial of telerobotics and the only trial comparing open, laparoscopic and robotic cystectomy. Twenty-five years ago, while at Queen Square, Prokar studied the role of C-fibres in overactive bladders (OAB) in humans and then developed a method of injecting botulinum toxin-A with a flexible telescope, the “Dasgupta technique”. International trials of the toxin led to its licensing for OAB, improved the quality of life of millions of patients worldwide and influenced National Institute of Health and Care Excellence (NICE) Guidelines. In recognition of his achievements, he received the Golden Telescope in 2006 and was appointed Professor of Robotic Surgery & Urological Innovation, KCL and Chairman of the King’s-Vattikuti Institute of Robotic Surgery. He was the 2020 recipient of the St. Peter’s Medal from the British Association of Urological Surgeons (BAUS). He has made major contributions to the study of mucosal cell biology, focusing on receptor function in the bladder and targeted immunotherapy in prostate cancer, receiving a patent for a first in man use of a cytotopic agent. Clinical chair of the Prostate Cancer Research Centre at KCL, he currently leads a large research team of basic scientists, engineers and clinician-scientists and has generated multi-million in grant income from the MRC, Wellcome Trust, EPSRC, UKRI, EU, the Guy’s and St. Thomas Charity and The Urology Foundation. Prokar has 1100 articles, H-index of 76 with >800 papers, 35 book chapters, 10 books, >500 presentations, >300 invited lectures and 50 Visiting Professorships. He has been Visiting Surgeon to Maharaja Gaj Singh II of Jodhpur, India. He is acknowledged as a leading educationalist, starting a successful BSc in Surgical Science at KCL, training over 200 students and looking for the evidence underpinning simulation in operative surgery, human factors and patient safety. He developed the world’s first laparoscopic nephrectomy simulator, led the EU-MARS project of the development and validation of robotic surgical training and the only international randomised trial of simulation for patient benefit – the SIMULATE study. He is a highly effective educator and communicator, editing the BJUI for 8 years, doubling its impact factor and achieving an Altmetric score of 1469. He led an international editorial team that revolutionized web-based publishing and the responsible use of social media. He brought innovative design, artificial intelligence (AI) and the new open access platform, BJUI Compass, to the BJUI family of journals. Prokar was elected the youngest ever, Hunterian President and served on the Associated Parliamentary Committee for Surgical Services in the House of Lords, UK. He is also known for his services to Charity, serving as a Trustee to the Prostate Cancer Research Centre and the Malcolm Coptcoat Trust. He is a mentor and advisor to the UK National Clinical Entrepreneurship Program. He has supported the careers of 16 UK and international academics, eight to Chairs. He has established several academic collaborations with Universities in Europe, India, the far East and Southern China. He is the Clinical Director of Surgical and Interventional Engineering at KCL, part of the ambitious MedTech Hub at St. Thomas’ Hospital with a budget of £110 million. He was awarded the Fellowship of the King’s College (FKC), King’s highest honour, membership of the Academic Association of European Urologists, the American Association of Genitourinary Surgeons and the Honorary Membership of the Urological Society of Australia and New Zealand. Prokar has supported BAUS in its core mission of education and research to enhance patient care. He has served on BAUS Council, Trustees, Regional Specialist Professional Advisor, Specialist Advisory Committee, Joint Committee for Surgical Training and examiner to the Intercollegiate Board. Nationally he is a member of the NICE Guidelines Panel and internationally he is a Founding member of the European Association of Urology Robotics Section (ERUS). During the COVID-19 crisis he published BJUI blogs from Italy, China, New Zealand and South Korea, which helped the planning of surgical services in the UK and internationally. With a team of international scientists, he studied trained immunity against the virus in health care workers after injection of BCG. He is a marathon runner, a reasonable cook and an avid tennis fan.
Sessions
  • “Future Surgery 2021 will be the first of its kind in the UK, drawing on the work our Commission on the Future of Surgery has done to predict the transformation in the medical care for millions of patients.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • “Driven by changes in digital technologies and our fast-evolving understanding of genomics, innovations are expected to affect how we undertake surgery, and how we train surgeons in future.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "Alongside the conference organisers, CloserStill, we aim to deliver a high-quality event that will provide both professional development and discussion space for surgeons and their teams."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "We look forward to welcoming colleagues to what promises to be a very high-quality programme and an exciting two days of thought-provoking training and engagement with medical suppliers."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England

EVENT PARTNER


 

PLATINUM SPONSOR

Edinurgh

PLATINUM SPONSOR

CMR

PLATINUM SPONSOR

quilter

GOLD SPONSOR


 

GOLD SPONSOR


 

GOLD SPONSOR

Sony

Sustainability Sponsor

SPONSOR

AneticAid

SPONSOR


 

SPONSOR


 

SPONSOR

Creed Medical

SPONSOR

Corza Medical

SPONSOR


 

SPONSOR

Epiqar

SPONSOR

Fundamental Surgery

SPONSOR


 

SPONSOR

Intuitive

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR

  • Open Medical

 

SPONSOR

  • 365 Healthcare

 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

British Orthopaedic Association

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

SSSIM

MEDIA PARTNER

CSJ

MEDIA PARTNER

Operating Theatre Journal